Preliminar evaluation of cytokines in the hepatitis C-schistosomiasis co-infection.
Evaluation of hepatic fibrosis is usually performed by histopathological examination of biopsies. However, this is an invasive and potentially dangerous procedure. Several studies have proposed serum biological markers of hepatic fibrosis. This communication evaluates the use of serum cytokines as markers of hepatic fibrosis in hepatitis C, schistosomiasis, and co-infection.
Morais
Clarice N L
CN
Centro de Pesquisas Aggeu Magalhães-Fiocruz, Av. Prof. Moraes Rego, 52020-020 Recife, PE, Brazil.
Carvalho
Bruno M
BM
Melo
Wlademir G
WG
Lopes
Edmundo P A
EP
Domingues
Ana Lúcia C
AL
Jucá
Norma T
NT
Souza
Wayner
W
Abath
Frederico G C
FG
Montenegro
Silvia M L
SM
D000328:Adult; D015415:Biomarkers / Q000097:blood; D016207:Cytokines / Q000097:blood* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006526:Hepatitis C / Q000150:complications / Q000276:immunology*; D006801:Humans; D018793:Interleukin-13 / Q000097:blood; D008103:Liver Cirrhosis / Q000276:immunology / Q000469:parasitology*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012552:Schistosomiasis / Q000150:complications / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000097:blood; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D015415:Biomarkers; D016207:Cytokines; D018793:Interleukin-13; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha